Clinical studies with DTIC (NSC-45388) in various malignancies
Slavik, M.
Cancer Treatment Reports 60(2): 213-214
1976
ISSN/ISBN: 0361-5960 PMID: 769976 Document Number: 106805
Document emailed within 1 workday
Related Documents
Usui, N. 2019: Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 859-861Bono, V.H. 1976: Studies on the mechanism of action of DTIC (NSC-45388) Cancer Treatment Reports 60(2): 141-148
Carbone, P.P.; Costello, W. 1976: Eastern Cooperative Oncology Group studies with DTIC (NSC-45388) Cancer Treatment Reports 60(2): 193-198
Disaia, P.J.; Nalick, R.H.; Townsend, D.E. 1973: Antibody cytotoxicity studies in ovarian and cervical malignancies Obstetrics and Gynecology 42(5): 644-650
Gupta, R.M.; Khanna, S.; Gupta, I.M. 1974: Serum protein paper and immuno-electrophoretic studies in lymphomyeloid malignancies Journal of the Indian Medical Association 62(11): 371-5 377-8
Murakami, H.; Saitoh, T.; Kasamatsu, T. 2016: Hematologic Malignancies/Pediatric Malignancies. III. Treatment of Relapsed/Refractory Multiple Myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(5): 539-544
Usui, N. 2017: Hematologic Malignancies/Pediatric Malignancies Acute Leukemia - Current Treatment and Future Perspective Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(5): 378-379
Usui, N. 2011: Hematologic malignancies/ pediatric malignancies-chronic myeloid leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(5): 744
Nagura, E.; Kawashima, K. 1986: Secondary malignancies associated with hematological malignancies following anticancer treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(4 Part 2): 1464-1474
Kokron, O.; Pridun, N.; Zischinsky, W. 1978: DTIC in the therapy of solid tumours Wiener Klinische Wochenschrift 90(24): 864-867
Wu, Y.-x.; Rui, W.-b.; Zhang, C.-y. 2006: Clinical analysis of 286 cases of renal malignancies Zhonghua Zhong Liu Za Zhi 28(5): 400
Balda, B.R.; Bassermann, R. 1980: Dacarbazine (DTIC) therapy and the Budd-Chiari syndrome Münchener Medizinische Wochenschrift 122(21): 792-794
Huber, H.; Grünewald, K. 1978: Dacarbacine (DTIC) in the therapy of a malignant disease. a review Wiener Klinische Wochenschrift 90(24): 861-864
Bolling, R.; Meyer-Hamme, S.; Schauder, S. 1980: Photosensitization with DTIC therapy in metastatic malignant melanoma Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 31(11): 602-605
Feigal, E.G.; Phillips, P.H.; Cheson, B.D. 1997: Clinical Trials Referral Resource. Clinical trials in AIDS related malignancies Oncology 11(3): 337-338; 341
Taitslin, V.I. 1972: Clinical characteristics of intracranial metastases from malignancies of different organs Vrachebnoe Delo 4: 118-120
Inoue, M.; Saitoh, J.; Abe, Y.; Inoue, Y.; Ueda, G.; Tanizawa, O.; Gamoh, Y.; Dan, A.; Satoh, T. 1985: Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies Nihon Sanka Fujinka Gakkai Zasshi 37(11): 2411-2414
Naito, K.; Kubo, K.; Akao, Y.; Hiraiwa, A.; Naoe, T.; Yamada, K. 1986: Clinical trial of bestrabucil (KM 2210) in hematopoietic malignancies Gan no Rinsho. Japan Journal of Cancer Clinics 32(11): 1443-1450
Dearden, C.E.; Matutes, E.; Catovsky, D. 2000: Clinical overview of pentostatin (Nipent) use in lymphoid malignancies Seminars in Oncology 27(2 Suppl 5: 22-26
Karakousis, C.P.; Didolkar, M.S.; Han, T. 1981: Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma Cancer Treatment Reports 65(9-10): 925-926